As of 2025-03-27, the Relative Valuation of Gritstone Oncology Inc (GRTS) is (170.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on Relative Valuation is -528951.7%.
The range of the Relative Valuation is (184.74) - (155.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 59.3x - 59.3x | 59.3x |
| Forward P/E multiples | 70.3x - 70.3x | 70.3x |
| Fair Price | (184.74) - (155.84) | (170.29) |
| Upside | -573838.8% - -484064.6% | -528951.7% |
| Date | P/E |